Tourette Syndrome
160
21
25
98
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
33 trials with published results (21%)
Research Maturity
98 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.5%
12 terminated out of 160 trials
89.1%
+2.6% vs benchmark
9%
14 trials in Phase 3/4
34%
33 of 98 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 98 completed trials
Clinical Trials (160)
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
SCI-110 in the Treatment of Tourette Syndrome
CBIT+TMS R33 Phase
Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome
A Multicenter Pediatric Deep Brain Stimulation Registry
Sensory Symptoms in Tourette Syndrome
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Observational Database on Deep Brain Stimulation in Tourette Syndrome
Characterising Sleep Disorders in Children With Tourette Syndrome
Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
Epidiolex in Obsessive Compulsive Disorder and Related Disorders
Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
Neural Correlates of Sensory Phenomena in Tourette Syndrome
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth
Tourette Discrimination (TD) Stigma Scale
Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study
Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder